124
Participants
Start Date
January 14, 2014
Primary Completion Date
September 12, 2018
Study Completion Date
September 12, 2018
Telotristat etiprate
Telotristat etiprate tablet (250 mg)
Lexicon Investigational Site, St Leonards
Lexicon Investigational Site, East Melbourne
Lexicon Investigational Site, Herston
Lexicon Investigational Site, Yvoir
Lexicon Investigational Site, Ghent
Lexicon Investigational Site, New York
Lexicon Investigational Site, Torino
Lexicon Investigational Site, Berlin
Lexicon Investigational Site, Philadelphia
Lexicon Investigational Site, Milan
Lexicon Investigational Site, Milan
Lexicon Investigational Site, Hamburg
Lexicon Investigational Site, Lund
Lexicon Investigational Site, Madrid
Lexicon Investigational Site, Marburg
Lexicon Investigational Site, Mobile
Lexicon Investigational Site, Lexington
Lexicon Investigational Site, Seville
Lexicon Investigational Site, Essen
Lexicon Investigational Site, Iowa City
Lexicon Investigational Site, Pisa
Lexicon Investigational Site, Lille
Lexicon Investigational Site, Lyon
Lexicon Investigational Site, Uppsala
Lexicon Investigational Site, Jerusalem
Lexicon Investigational Site, Stanford
Lexicon Investigational Site, Villejuif
Lexicon Investigational Site, Bad Berka
Lexicon Investigational Site, Boston
Lexicon Investigational Site, Edegem
Lexicon Investgational Site, Calgary
Lexicon Investigational Site, Halifax
Lexicon Investigational Site, Amsterdam
Lexicon Investigational Site, Noord Holland
Lexicon Investigational Site, Noord-Brahant
Lexicon Investigational Site, Barcelona
Lexicon Investigational Site, Coventry
Lexicon Investigational Site, Glasgow
Lexicon Investigational Site, London
Lexicon Investigational Site, London
Lexicon Investigational Site, London
Lexicon Investigational Site, Manchester
Lexicon Investigational Site, Newcastle upon Tyne
Lead Sponsor
Lexicon Pharmaceuticals
INDUSTRY